

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | cardiac myofibril assembly (GO:0055003) | 9.12962190 |
| 2 | sarcomere organization (GO:0045214) | 8.65342820 |
| 3 | myofibril assembly (GO:0030239) | 7.72808603 |
| 4 | regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion (GO | 7.26163219 |
| 5 | cardiac muscle contraction (GO:0060048) | 7.08698779 |
| 6 | negative regulation of potassium ion transmembrane transporter activity (GO:1901017) | 7.03565024 |
| 7 | regulation of relaxation of muscle (GO:1901077) | 6.93536493 |
| 8 | regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum (GO:0010880) | 6.72567724 |
| 9 | negative regulation of potassium ion transmembrane transport (GO:1901380) | 6.59598469 |
| 10 | regulation of cardiac muscle contraction by calcium ion signaling (GO:0010882) | 6.45857505 |
| 11 | muscle filament sliding (GO:0030049) | 6.45262807 |
| 12 | actin-myosin filament sliding (GO:0033275) | 6.45262807 |
| 13 | regulation of sarcomere organization (GO:0060297) | 6.39483669 |
| 14 | cardiac muscle cell development (GO:0055013) | 6.33619200 |
| 15 | cardiac muscle hypertrophy (GO:0003300) | 6.32393411 |
| 16 | positive regulation of ryanodine-sensitive calcium-release channel activity (GO:0060316) | 6.30718998 |
| 17 | cardiac muscle tissue morphogenesis (GO:0055008) | 6.30690540 |
| 18 | tricarboxylic acid cycle (GO:0006099) | 6.21408138 |
| 19 | regulation of actin filament-based movement (GO:1903115) | 6.12714242 |
| 20 | ventricular cardiac muscle tissue morphogenesis (GO:0055010) | 5.97522217 |
| 21 | cardiac cell development (GO:0055006) | 5.94711395 |
| 22 | striated muscle hypertrophy (GO:0014897) | 5.92889326 |
| 23 | adult heart development (GO:0007512) | 5.85981017 |
| 24 | bundle of His cell to Purkinje myocyte communication (GO:0086069) | 5.79008993 |
| 25 | cell communication by electrical coupling involved in cardiac conduction (GO:0086064) | 5.66822780 |
| 26 | ventricular cardiac muscle cell action potential (GO:0086005) | 5.58269876 |
| 27 | heart contraction (GO:0060047) | 5.56907209 |
| 28 | heart process (GO:0003015) | 5.56907209 |
| 29 | muscle tissue morphogenesis (GO:0060415) | 5.55596131 |
| 30 | actomyosin structure organization (GO:0031032) | 5.51507182 |
| 31 | actin-mediated cell contraction (GO:0070252) | 5.46551941 |
| 32 | muscle hypertrophy (GO:0014896) | 5.32695876 |
| 33 | regulation of the force of heart contraction (GO:0002026) | 5.19843578 |
| 34 | regulation of striated muscle contraction (GO:0006942) | 5.15273067 |
| 35 | heart trabecula formation (GO:0060347) | 5.08487185 |
| 36 | striated muscle contraction (GO:0006941) | 5.07992090 |
| 37 | negative regulation of cardiac muscle cell apoptotic process (GO:0010667) | 4.96943883 |
| 38 | regulation of acetyl-CoA biosynthetic process from pyruvate (GO:0010510) | 4.95993216 |
| 39 | cell communication involved in cardiac conduction (GO:0086065) | 4.95642159 |
| 40 | regulation of cell communication by electrical coupling (GO:0010649) | 4.95268648 |
| 41 | regulation of ventricular cardiac muscle cell membrane repolarization (GO:0060307) | 4.90669095 |
| 42 | regulation of skeletal muscle contraction (GO:0014819) | 4.86623052 |
| 43 | regulation of cardioblast differentiation (GO:0051890) | 4.85201223 |
| 44 | cell communication by electrical coupling (GO:0010644) | 4.83639175 |
| 45 | regulation of ryanodine-sensitive calcium-release channel activity (GO:0060314) | 4.68384815 |
| 46 | regulation of membrane repolarization (GO:0060306) | 4.66778909 |
| 47 | relaxation of cardiac muscle (GO:0055119) | 4.65158103 |
| 48 | regulation of cardiac muscle contraction (GO:0055117) | 4.61703079 |
| 49 | sarcoplasmic reticulum calcium ion transport (GO:0070296) | 4.59159869 |
| 50 | negative regulation of striated muscle cell apoptotic process (GO:0010664) | 4.57892619 |
| 51 | behavioral response to nicotine (GO:0035095) | 4.49529904 |
| 52 | regulation of acyl-CoA biosynthetic process (GO:0050812) | 4.47602988 |
| 53 | tryptophan catabolic process (GO:0006569) | 4.43521796 |
| 54 | indole-containing compound catabolic process (GO:0042436) | 4.43521796 |
| 55 | indolalkylamine catabolic process (GO:0046218) | 4.43521796 |
| 56 | regulation of cardiac muscle cell contraction (GO:0086004) | 4.41853021 |
| 57 | cardiac chamber formation (GO:0003207) | 4.41781756 |
| 58 | negative regulation of cytosolic calcium ion concentration (GO:0051481) | 4.40745800 |
| 59 | carnitine shuttle (GO:0006853) | 4.33883654 |
| 60 | cardiac muscle hypertrophy in response to stress (GO:0014898) | 4.32845756 |
| 61 | muscle hypertrophy in response to stress (GO:0003299) | 4.32845756 |
| 62 | cardiac muscle adaptation (GO:0014887) | 4.32845756 |
| 63 | cardiac muscle cell action potential (GO:0086001) | 4.20807010 |
| 64 | regulation of heart rate (GO:0002027) | 4.20024006 |
| 65 | indolalkylamine metabolic process (GO:0006586) | 4.19046102 |
| 66 | cardiac muscle cell action potential involved in contraction (GO:0086002) | 4.18661760 |
| 67 | oxidative phosphorylation (GO:0006119) | 4.15039110 |
| 68 | regulation of cofactor metabolic process (GO:0051193) | 4.14395166 |
| 69 | regulation of coenzyme metabolic process (GO:0051196) | 4.14395166 |
| 70 | plasma membrane repair (GO:0001778) | 4.08479028 |
| 71 | actin filament-based movement (GO:0030048) | 4.06184389 |
| 72 | mitochondrial ATP synthesis coupled proton transport (GO:0042776) | 3.99510061 |
| 73 | cardiac conduction (GO:0061337) | 3.98059641 |
| 74 | kynurenine metabolic process (GO:0070189) | 3.97549652 |
| 75 | regulation of ATPase activity (GO:0043462) | 3.91147235 |
| 76 | regulation of ATP catabolic process (GO:1903289) | 3.91147235 |
| 77 | tryptophan metabolic process (GO:0006568) | 3.90579876 |
| 78 | regulation of heart contraction (GO:0008016) | 3.90343346 |
| 79 | atrial septum morphogenesis (GO:0060413) | 3.88594915 |
| 80 | venous blood vessel morphogenesis (GO:0048845) | 3.81703849 |
| 81 | response to stimulus involved in regulation of muscle adaptation (GO:0014874) | 3.79359467 |
| 82 | glucocorticoid biosynthetic process (GO:0006704) | 3.78308847 |
| 83 | detection of mechanical stimulus involved in sensory perception of sound (GO:0050910) | 3.76954449 |
| 84 | regulation of heart rate by cardiac conduction (GO:0086091) | 3.75931344 |
| 85 | negative regulation of potassium ion transport (GO:0043267) | 3.72216875 |
| 86 | mitochondrial electron transport, NADH to ubiquinone (GO:0006120) | 3.71331858 |
| 87 | fucose catabolic process (GO:0019317) | 3.70058706 |
| 88 | L-fucose metabolic process (GO:0042354) | 3.70058706 |
| 89 | L-fucose catabolic process (GO:0042355) | 3.70058706 |
| 90 | ATP synthesis coupled proton transport (GO:0015986) | 3.68630558 |
| 91 | energy coupled proton transport, down electrochemical gradient (GO:0015985) | 3.68630558 |
| 92 | NADH metabolic process (GO:0006734) | 3.67401971 |
| 93 | respiratory electron transport chain (GO:0022904) | 3.65935566 |
| 94 | fatty acid transmembrane transport (GO:1902001) | 3.65446561 |
| 95 | positive regulation of heart rate (GO:0010460) | 3.62215262 |
| 96 | detection of calcium ion (GO:0005513) | 3.61656645 |
| 97 | ventricular cardiac muscle cell development (GO:0055015) | 3.59556303 |
| 98 | outflow tract septum morphogenesis (GO:0003148) | 3.56440467 |
| 99 | electron transport chain (GO:0022900) | 3.55611158 |
| 100 | benzene-containing compound metabolic process (GO:0042537) | 3.54602992 |
| 101 | regulation of muscle contraction (GO:0006937) | 3.54343101 |
| 102 | positive regulation of calcium ion transmembrane transporter activity (GO:1901021) | 3.47180171 |
| 103 | negative regulation of mast cell activation (GO:0033004) | 3.45776750 |
| 104 | platelet dense granule organization (GO:0060155) | 3.43142197 |
| 105 | regulation of striated muscle cell apoptotic process (GO:0010662) | 3.42871148 |
| 106 | positive regulation of heart contraction (GO:0045823) | 3.42792067 |
| 107 | response to epinephrine (GO:0071871) | 3.40884507 |
| 108 | striated muscle cell development (GO:0055002) | 3.36100312 |
| 109 | potassium ion export (GO:0071435) | 3.34102579 |
| 110 | regulation of sulfur metabolic process (GO:0042762) | 3.32097613 |
| 111 | cardiac muscle tissue development (GO:0048738) | 3.30814726 |
| 112 | cellular response to epinephrine stimulus (GO:0071872) | 3.29587272 |
| 113 | cardiac ventricle formation (GO:0003211) | 3.28356189 |
| 114 | doxorubicin metabolic process (GO:0044598) | 3.25861132 |
| 115 | daunorubicin metabolic process (GO:0044597) | 3.25861132 |
| 116 | response to pheromone (GO:0019236) | 3.25731699 |
| 117 | cellular biogenic amine catabolic process (GO:0042402) | 3.21108707 |
| 118 | amine catabolic process (GO:0009310) | 3.21108707 |
| 119 | detection of light stimulus involved in visual perception (GO:0050908) | 3.13475626 |
| 120 | detection of light stimulus involved in sensory perception (GO:0050962) | 3.13475626 |
| 121 | indole-containing compound metabolic process (GO:0042430) | 3.13165576 |
| 122 | negative regulation of systemic arterial blood pressure (GO:0003085) | 3.08467663 |
| 123 | NAD biosynthetic process (GO:0009435) | 3.08099138 |
| 124 | auditory receptor cell stereocilium organization (GO:0060088) | 3.01730920 |
| 125 | piRNA metabolic process (GO:0034587) | 2.95422490 |
| 126 | water-soluble vitamin biosynthetic process (GO:0042364) | 2.95061152 |
| 127 | photoreceptor cell maintenance (GO:0045494) | 2.88355628 |
| 128 | reflex (GO:0060004) | 2.86188112 |
| 129 | cellular ketone body metabolic process (GO:0046950) | 2.84025056 |
| 130 | phosphatidylinositol acyl-chain remodeling (GO:0036149) | 2.79199445 |
| 131 | protein K11-linked deubiquitination (GO:0035871) | 2.79123500 |
| 132 | androgen biosynthetic process (GO:0006702) | 2.77631616 |
| 133 | behavioral response to ethanol (GO:0048149) | 2.76665597 |
| 134 | protein polyglutamylation (GO:0018095) | 2.73725302 |
| 135 | epithelial cilium movement involved in determination of left/right asymmetry (GO:0060287) | 2.72065273 |
| 136 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 2.70453786 |
| 137 | positive regulation of triglyceride biosynthetic process (GO:0010867) | 2.70259390 |
| 138 | tachykinin receptor signaling pathway (GO:0007217) | 2.69246970 |
| 139 | gamma-aminobutyric acid transport (GO:0015812) | 2.65204543 |
| 140 | sulfation (GO:0051923) | 2.64712559 |
| 141 | negative regulation of reactive oxygen species metabolic process (GO:2000378) | 2.63482777 |
| 142 | intracellular pH reduction (GO:0051452) | 2.61795698 |
| 143 | regulation of cilium movement (GO:0003352) | 2.60660710 |
| 144 | positive regulation of prostaglandin secretion (GO:0032308) | 2.59912572 |
| 145 | proline transport (GO:0015824) | 2.59565121 |
| 146 | estrogen biosynthetic process (GO:0006703) | 2.58833064 |
| 147 | amino sugar catabolic process (GO:0046348) | 2.58821326 |
| 148 | neural tube formation (GO:0001841) | 2.58099977 |
| 149 | nonmotile primary cilium assembly (GO:0035058) | 2.56356621 |
| 150 | neuronal action potential (GO:0019228) | 2.56193872 |
| 151 | synaptic transmission, cholinergic (GO:0007271) | 2.55129281 |
| 152 | transepithelial transport (GO:0070633) | 2.54459683 |
| 153 | regulation of triglyceride biosynthetic process (GO:0010866) | 2.53211128 |
| 154 | ketone body metabolic process (GO:1902224) | 2.52642621 |
| 155 | adaptation of signaling pathway (GO:0023058) | 2.52287239 |
| 156 | axoneme assembly (GO:0035082) | 2.51972295 |
| 157 | DNA deamination (GO:0045006) | 2.50777401 |
| 158 | membrane depolarization during action potential (GO:0086010) | 2.50714434 |
| 159 | DNA methylation involved in gamete generation (GO:0043046) | 2.47930703 |
| 160 | primary amino compound metabolic process (GO:1901160) | 2.46301715 |
| 161 | G-protein coupled glutamate receptor signaling pathway (GO:0007216) | 2.45947617 |
| 162 | sphingoid metabolic process (GO:0046519) | 2.45560097 |
| 163 | pyrimidine nucleobase catabolic process (GO:0006208) | 2.43690318 |
| 164 | inner ear receptor stereocilium organization (GO:0060122) | 2.43055351 |
| 165 | regulation of hippo signaling (GO:0035330) | 2.42462656 |
| 166 | cellular response to sterol (GO:0036315) | 2.42023684 |
| 167 | regulation of female gonad development (GO:2000194) | 2.41653288 |
| 168 | alanine transport (GO:0032328) | 2.40454086 |
| 169 | positive regulation of digestive system process (GO:0060456) | 2.38484467 |
| 170 | atrial cardiac muscle cell action potential (GO:0086014) | 2.37946912 |
| 171 | positive regulation of fatty acid transport (GO:2000193) | 2.36651364 |
| 172 | cAMP catabolic process (GO:0006198) | 2.35463014 |
| 173 | multicellular organism reproduction (GO:0032504) | 2.35146994 |
| 174 | glycerophospholipid catabolic process (GO:0046475) | 2.34403539 |
| 175 | cellular response to gonadotropin stimulus (GO:0071371) | 2.34293471 |
| 176 | positive regulation of developmental pigmentation (GO:0048087) | 2.33760844 |
| 177 | epithelial cilium movement (GO:0003351) | 2.31975278 |
| 178 | serotonin metabolic process (GO:0042428) | 2.31876627 |
| 179 | protein localization to cilium (GO:0061512) | 2.31216690 |
| 180 | regulation of microtubule-based movement (GO:0060632) | 2.31115688 |
| 181 | photoreceptor cell development (GO:0042461) | 2.30627246 |
| 182 | hormone biosynthetic process (GO:0042446) | 2.27847018 |
| 183 | glucocorticoid metabolic process (GO:0008211) | 2.26596153 |
| 184 | negative regulation of telomere maintenance (GO:0032205) | 2.24826763 |
| 185 | ganglioside metabolic process (GO:0001573) | 2.24674279 |
| 186 | sulfate transmembrane transport (GO:1902358) | 2.23903741 |
| 187 | aromatic amino acid family catabolic process (GO:0009074) | 2.23900931 |
| 188 | vitamin D metabolic process (GO:0042359) | 2.22946699 |
| 189 | regulation of action potential (GO:0098900) | 2.22607787 |
| 190 | cilium morphogenesis (GO:0060271) | 2.22457254 |
| 191 | negative regulation of nitric oxide biosynthetic process (GO:0045019) | 2.22187778 |
| 192 | pyridine nucleotide biosynthetic process (GO:0019363) | 2.21964471 |
| 193 | nicotinamide nucleotide biosynthetic process (GO:0019359) | 2.21964471 |
| 194 | positive regulation of organic acid transport (GO:0032892) | 2.19633208 |
| 195 | thyroid hormone metabolic process (GO:0042403) | 2.19476256 |
| 196 | retinal cone cell development (GO:0046549) | 2.19453841 |
| 197 | parturition (GO:0007567) | 2.19172476 |
| 198 | neuronal action potential propagation (GO:0019227) | 2.18748902 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | * EP300_21415370_ChIP-Seq_HL-1_Mouse | 6.10093023 |
| 2 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 5.00481271 |
| 3 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 4.00339807 |
| 4 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 3.97031622 |
| 5 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 3.97031622 |
| 6 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 3.76622756 |
| 7 | MEF2A_21415370_ChIP-Seq_HL-1_Mouse | 3.37849543 |
| 8 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 3.28331277 |
| 9 | VDR_22108803_ChIP-Seq_LS180_Human | 3.26565140 |
| 10 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 3.11343325 |
| 11 | GATA4_21415370_ChIP-Seq_HL-1_Mouse | 2.89981249 |
| 12 | EZH2_22144423_ChIP-Seq_EOC_Human | 2.82805528 |
| 13 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 2.81101430 |
| 14 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 2.75411085 |
| 15 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 2.74745045 |
| 16 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 2.60637038 |
| 17 | GATA1_22025678_ChIP-Seq_K562_Human | 2.54831103 |
| 18 | EP300_20729851_ChIP-Seq_FORBRAIN_MIDBRAIN_LIMB_HEART_Mouse | 2.29149890 |
| 19 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 2.28497964 |
| 20 | IGF1R_20145208_ChIP-Seq_DFB_Human | 2.24582608 |
| 21 | TAF15_26573619_Chip-Seq_HEK293_Human | 2.14836858 |
| 22 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 2.13553895 |
| 23 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 2.12978171 |
| 24 | P300_19829295_ChIP-Seq_ESCs_Human | 2.05950461 |
| 25 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 1.91475049 |
| 26 | NKX2-5_21415370_ChIP-Seq_HL-1_Mouse | 1.91027840 |
| 27 | GBX2_23144817_ChIP-Seq_PC3_Human | 1.90811119 |
| 28 | * AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.83761089 |
| 29 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.83207448 |
| 30 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.79591203 |
| 31 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.73573514 |
| 32 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 1.71251057 |
| 33 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.70169809 |
| 34 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.69586803 |
| 35 | * LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.68261464 |
| 36 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.67586088 |
| 37 | FUS_26573619_Chip-Seq_HEK293_Human | 1.67322712 |
| 38 | POU5F1_26923725_Chip-Seq_MESODERM_Mouse | 1.64741506 |
| 39 | TEAD4_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.64741506 |
| 40 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 1.62959435 |
| 41 | EWS_26573619_Chip-Seq_HEK293_Human | 1.62608831 |
| 42 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.61166292 |
| 43 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 1.60525283 |
| 44 | * AR_25329375_ChIP-Seq_VCAP_Human | 1.60020169 |
| 45 | STAT3_23295773_ChIP-Seq_U87_Human | 1.58908198 |
| 46 | ISL1_27105846_Chip-Seq_CPCs_Mouse | 1.57453721 |
| 47 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.57091215 |
| 48 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.54917873 |
| 49 | CBP_20019798_ChIP-Seq_JUKART_Human | 1.53924619 |
| 50 | IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 1.53924619 |
| 51 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 1.53204131 |
| 52 | EWS-ERG_20517297_ChIP-Seq_CADO-ES1_Human | 1.48614073 |
| 53 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 1.47376026 |
| 54 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.43308458 |
| 55 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 1.43181211 |
| 56 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.42513118 |
| 57 | * SOX2_19829295_ChIP-Seq_ESCs_Human | 1.38309691 |
| 58 | * NANOG_19829295_ChIP-Seq_ESCs_Human | 1.38309691 |
| 59 | SMAD4_21741376_ChIP-Seq_EPCs_Human | 1.37982568 |
| 60 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 1.35478023 |
| 61 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 1.35431134 |
| 62 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 1.35210501 |
| 63 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 1.34351734 |
| 64 | MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 1.34221365 |
| 65 | DROSHA_22980978_ChIP-Seq_HELA_Human | 1.34154968 |
| 66 | * SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.34050537 |
| 67 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 1.33955456 |
| 68 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.33888634 |
| 69 | * TCF4_22108803_ChIP-Seq_LS180_Human | 1.32203090 |
| 70 | MYC_20876797_ChIP-ChIP_MEDULLOBLASTOMA_Human | 1.30543494 |
| 71 | TP53_22573176_ChIP-Seq_HFKS_Human | 1.29506872 |
| 72 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 1.27693682 |
| 73 | TRIM28_17542650_ChIP-ChIP_NTERA2_Human | 1.27028964 |
| 74 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 1.25973702 |
| 75 | RUNX2_22187159_ChIP-Seq_PCA_Human | 1.24473841 |
| 76 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 1.23748716 |
| 77 | KLF5_20875108_ChIP-Seq_MESCs_Mouse | 1.23632944 |
| 78 | FLI1_21867929_ChIP-Seq_TH2_Mouse | 1.22914280 |
| 79 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 1.22594352 |
| 80 | PRDM14_20953172_ChIP-Seq_ESCs_Human | 1.22151416 |
| 81 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 1.21504380 |
| 82 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.21128575 |
| 83 | * REST_21632747_ChIP-Seq_MESCs_Mouse | 1.20733985 |
| 84 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.20349524 |
| 85 | CRX_20693478_ChIP-Seq_RETINA_Mouse | 1.18951245 |
| 86 | CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 1.18536975 |
| 87 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 1.17745693 |
| 88 | BCAT_22108803_ChIP-Seq_LS180_Human | 1.17313496 |
| 89 | SMAD3_21741376_ChIP-Seq_HESCs_Human | 1.16793135 |
| 90 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 1.16735946 |
| 91 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 1.14200452 |
| 92 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 1.14200452 |
| 93 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 1.13876136 |
| 94 | * OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.13568280 |
| 95 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.13046730 |
| 96 | FOXA1_21572438_ChIP-Seq_LNCaP_Human | 1.12317336 |
| 97 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 1.09450114 |
| 98 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 1.09327285 |
| 99 | IRF1_19129219_ChIP-ChIP_H3396_Human | 1.08028912 |
| 100 | TCF4_18268006_ChIP-ChIP_LS174T_Human | 1.07383763 |
| 101 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.07090698 |
| 102 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 1.06993571 |
| 103 | * GATA3_21878914_ChIP-Seq_MCF-7_Human | 1.06480596 |
| 104 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.06275632 |
| 105 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.06267237 |
| 106 | WT1_19549856_ChIP-ChIP_CCG9911_Human | 1.06140053 |
| 107 | SMAD4_21741376_ChIP-Seq_HESCs_Human | 1.06114599 |
| 108 | NANOG_18555785_Chip-Seq_ESCs_Mouse | 1.05309101 |
| 109 | EBF1_22473956_ChIP-Seq_BONE_MARROW_Mouse | 1.05146492 |
| 110 | GATA1_19941826_ChIP-Seq_K562_Human | 1.05055148 |
| 111 | TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 1.05039894 |
| 112 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.04984445 |
| 113 | * CDX2_22108803_ChIP-Seq_LS180_Human | 1.04719101 |
| 114 | ETV2_25802403_ChIP-Seq_MESCs_Mouse | 1.04450799 |
| 115 | * BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.04402232 |
| 116 | MYCN_21190229_ChIP-Seq_SHEP-21N_Human | 1.04386406 |
| 117 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 1.03531992 |
| 118 | GRHL2_25758223_ChIP-Seq_PLACENTA_Mouse | 1.03271491 |
| 119 | HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 1.03224223 |
| 120 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.02978756 |
| 121 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 1.02435160 |
| 122 | TAL1_21186366_ChIP-Seq_BM-HSCs_Mouse | 1.02097970 |
| 123 | OCT4_21477851_ChIP-Seq_ESCs_Mouse | 1.01589735 |
| 124 | FOXA1_25329375_ChIP-Seq_VCAP_Human | 1.01519153 |
| 125 | FOXA1_27270436_Chip-Seq_PROSTATE_Human | 1.01519153 |
| 126 | SOX2_21211035_ChIP-Seq_LN229_Gbm | 1.01382509 |
| 127 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.01284747 |
| 128 | CTNNB1_20460455_ChIP-Seq_HCT116_Human | 1.01280134 |
| 129 | RNF2_27304074_Chip-Seq_NSC_Mouse | 1.00958885 |
| 130 | AR_20517297_ChIP-Seq_VCAP_Human | 1.00295482 |
| 131 | MEIS1_26923725_Chip-Seq_HEMOGENIC-ENDOTHELIUM_Mouse | 1.00184503 |
| 132 | TP53_16413492_ChIP-PET_HCT116_Human | 0.99718411 |
| 133 | * GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.99364096 |
| 134 | TAL1_26923725_Chip-Seq_HPCs_Mouse | 0.98595558 |
| 135 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 0.97834136 |
| 136 | HOXB7_26014856_ChIP-Seq_BT474_Human | 0.97714919 |
| 137 | CEBPB_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.96912110 |
| 138 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 0.96878224 |
| 139 | TEAD4_22529382_ChIP-Seq_TROPHECTODERM_Mouse | 0.96325248 |
| 140 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 0.95044189 |
| 141 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.91644563 |
| 142 | TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.91262439 |
| 143 | GATA2_19941826_ChIP-Seq_K562_Human | 0.91012338 |
| 144 | GF1_26923725_Chip-Seq_HPCs_Mouse | 0.90860958 |
| 145 | CJUN_26792858_Chip-Seq_BT549_Human | 0.90456797 |
| 146 | WT1_25993318_ChIP-Seq_PODOCYTE_Human | 0.89579013 |
| 147 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 0.89480687 |
| 148 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 0.89253451 |
| 149 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 0.87353954 |
| 150 | * GATA1_19941827_ChIP-Seq_MEL86_Mouse | 0.86275817 |
| 151 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 0.85883658 |
| 152 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 0.85756739 |
| 153 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 0.85426516 |
| 154 | AHR_22903824_ChIP-Seq_MCF-7_Human | 0.85319508 |
| 155 | PCGF4_22325352_ChIP-Seq_293T-Rex_Human | 0.84660168 |
| 156 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 0.84486552 |
| 157 | DMRT1_21621532_ChIP-ChIP_FETAL_Ovary | 0.84368587 |
| 158 | * LMO2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.83917190 |
| 159 | AUTS2_25519132_ChIP-Seq_293T-REX_Human | 0.83103796 |
| 160 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 0.82913779 |
| 161 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 0.81272989 |
| 162 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 0.79056108 |
| 163 | SPI1_23127762_ChIP-Seq_K562_Human | 0.78206416 |
| 164 | * SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.74928231 |
| 165 | AR_19668381_ChIP-Seq_PC3_Human | 0.74089826 |
| 166 | TCF4_23295773_ChIP-Seq_U87_Human | 0.73766008 |
| 167 | PPARG_20176806_ChIP-Seq_3T3-L1_Mouse | 0.73566800 |
| 168 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 0.72704433 |
| 169 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.72253702 |
| 170 | KLF1_20508144_ChIP-Seq_FETAL-LIVER-ERYTHROID_Mouse | 0.72036750 |
| 171 | NFI_21473784_ChIP-Seq_ESCs_Mouse | 0.70962278 |
| 172 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 0.70693432 |
| 173 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 0.70468383 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0004084_abnormal_cardiac_muscle | 6.63424768 |
| 2 | MP0002837_dystrophic_cardiac_calcinosis | 6.20187482 |
| 3 | MP0004215_abnormal_myocardial_fiber | 5.30452008 |
| 4 | MP0003646_muscle_fatigue | 4.71679006 |
| 5 | MP0004036_abnormal_muscle_relaxation | 4.52535590 |
| 6 | MP0000751_myopathy | 4.36220381 |
| 7 | MP0005330_cardiomyopathy | 4.06874773 |
| 8 | MP0000749_muscle_degeneration | 3.67280943 |
| 9 | MP0002972_abnormal_cardiac_muscle | 3.61209126 |
| 10 | MP0008775_abnormal_heart_ventricle | 3.52944025 |
| 11 | MP0003137_abnormal_impulse_conducting | 3.27581178 |
| 12 | MP0001544_abnormal_cardiovascular_syste | 2.89808542 |
| 13 | MP0005385_cardiovascular_system_phenoty | 2.89808542 |
| 14 | MP0010630_abnormal_cardiac_muscle | 2.89007095 |
| 15 | MP0003195_calcinosis | 2.86145232 |
| 16 | MP0004087_abnormal_muscle_fiber | 2.85365648 |
| 17 | MP0005620_abnormal_muscle_contractility | 2.84355912 |
| 18 | MP0004484_altered_response_of | 2.82714001 |
| 19 | MP0003828_pulmonary_edema | 2.80017320 |
| 20 | MP0006138_congestive_heart_failure | 2.74451004 |
| 21 | MP0002102_abnormal_ear_morphology | 2.68114023 |
| 22 | MP0004510_myositis | 2.63313347 |
| 23 | * MP0004085_abnormal_heartbeat | 2.61508840 |
| 24 | MP0002138_abnormal_hepatobiliary_system | 2.57007596 |
| 25 | MP0000569_abnormal_digit_pigmentation | 2.54428219 |
| 26 | MP0005551_abnormal_eye_electrophysiolog | 2.43983738 |
| 27 | MP0003136_yellow_coat_color | 2.26875164 |
| 28 | MP0002127_abnormal_cardiovascular_syste | 2.26055279 |
| 29 | MP0002106_abnormal_muscle_physiology | 2.24848075 |
| 30 | MP0000750_abnormal_muscle_regeneration | 2.12056611 |
| 31 | MP0001968_abnormal_touch/_nociception | 2.10379859 |
| 32 | MP0003221_abnormal_cardiomyocyte_apopto | 2.06060341 |
| 33 | MP0004130_abnormal_muscle_cell | 2.03326337 |
| 34 | MP0009046_muscle_twitch | 1.98547473 |
| 35 | MP0001485_abnormal_pinna_reflex | 1.96947896 |
| 36 | MP0001501_abnormal_sleep_pattern | 1.96557445 |
| 37 | MP0005167_abnormal_blood-brain_barrier | 1.91907212 |
| 38 | MP0002269_muscular_atrophy | 1.89335091 |
| 39 | MP0005253_abnormal_eye_physiology | 1.85708122 |
| 40 | MP0004145_abnormal_muscle_electrophysio | 1.85660224 |
| 41 | MP0003567_abnormal_fetal_cardiomyocyte | 1.81004479 |
| 42 | MP0005369_muscle_phenotype | 1.80758188 |
| 43 | MP0008875_abnormal_xenobiotic_pharmacok | 1.75180297 |
| 44 | MP0003950_abnormal_plasma_membrane | 1.66621322 |
| 45 | MP0010386_abnormal_urinary_bladder | 1.66312127 |
| 46 | MP0006036_abnormal_mitochondrial_physio | 1.61703263 |
| 47 | MP0001486_abnormal_startle_reflex | 1.58813770 |
| 48 | MP0008877_abnormal_DNA_methylation | 1.58790583 |
| 49 | MP0000759_abnormal_skeletal_muscle | 1.53674005 |
| 50 | MP0009745_abnormal_behavioral_response | 1.52284891 |
| 51 | MP0004233_abnormal_muscle_weight | 1.50352030 |
| 52 | MP0010368_abnormal_lymphatic_system | 1.47292605 |
| 53 | MP0002090_abnormal_vision | 1.46598212 |
| 54 | MP0002736_abnormal_nociception_after | 1.45238222 |
| 55 | MP0003011_delayed_dark_adaptation | 1.42583043 |
| 56 | MP0002254_reproductive_system_inflammat | 1.41404459 |
| 57 | MP0002332_abnormal_exercise_endurance | 1.41175752 |
| 58 | MP0001986_abnormal_taste_sensitivity | 1.40395680 |
| 59 | MP0006276_abnormal_autonomic_nervous | 1.40282804 |
| 60 | MP0000372_irregular_coat_pigmentation | 1.39016064 |
| 61 | MP0002653_abnormal_ependyma_morphology | 1.38759115 |
| 62 | MP0002876_abnormal_thyroid_physiology | 1.35547499 |
| 63 | MP0006082_CNS_inflammation | 1.35044954 |
| 64 | MP0002272_abnormal_nervous_system | 1.34278957 |
| 65 | MP0002229_neurodegeneration | 1.30118849 |
| 66 | MP0005410_abnormal_fertilization | 1.29737343 |
| 67 | MP0000266_abnormal_heart_morphology | 1.29457457 |
| 68 | MP0003172_abnormal_lysosome_physiology | 1.28914512 |
| 69 | MP0002064_seizures | 1.27103169 |
| 70 | MP0003880_abnormal_central_pattern | 1.24874344 |
| 71 | MP0002572_abnormal_emotion/affect_behav | 1.24785246 |
| 72 | MP0000747_muscle_weakness | 1.24719261 |
| 73 | MP0000343_altered_response_to | 1.24300661 |
| 74 | MP0002557_abnormal_social/conspecific_i | 1.22018076 |
| 75 | MP0005365_abnormal_bile_salt | 1.21704098 |
| 76 | MP0001970_abnormal_pain_threshold | 1.21422265 |
| 77 | MP0005165_increased_susceptibility_to | 1.19802590 |
| 78 | MP0000427_abnormal_hair_cycle | 1.19108353 |
| 79 | MP0009764_decreased_sensitivity_to | 1.18792725 |
| 80 | MP0005645_abnormal_hypothalamus_physiol | 1.17768192 |
| 81 | MP0000639_abnormal_adrenal_gland | 1.14007933 |
| 82 | MP0005310_abnormal_salivary_gland | 1.13447100 |
| 83 | MP0000230_abnormal_systemic_arterial | 1.10381729 |
| 84 | MP0002733_abnormal_thermal_nociception | 1.10099327 |
| 85 | MP0002638_abnormal_pupillary_reflex | 1.09957666 |
| 86 | MP0000383_abnormal_hair_follicle | 1.09714314 |
| 87 | MP0004742_abnormal_vestibular_system | 1.08646363 |
| 88 | MP0000631_abnormal_neuroendocrine_gland | 1.08607085 |
| 89 | MP0009840_abnormal_foam_cell | 1.08079903 |
| 90 | MP0008872_abnormal_physiological_respon | 1.07982576 |
| 91 | MP0001324_abnormal_eye_pigmentation | 1.07773519 |
| 92 | MP0000604_amyloidosis | 1.07601300 |
| 93 | MP0003879_abnormal_hair_cell | 1.06049823 |
| 94 | MP0002735_abnormal_chemical_nociception | 1.05045372 |
| 95 | MP0000538_abnormal_urinary_bladder | 1.03287042 |
| 96 | MP0002067_abnormal_sensory_capabilities | 1.01895440 |
| 97 | MP0005670_abnormal_white_adipose | 1.01839304 |
| 98 | MP0003279_aneurysm | 1.00786974 |
| 99 | MP0003633_abnormal_nervous_system | 1.00005593 |
| 100 | MP0005058_abnormal_lysosome_morphology | 0.98678968 |
| 101 | MP0001963_abnormal_hearing_physiology | 0.97648674 |
| 102 | MP0004133_heterotaxia | 0.95389792 |
| 103 | MP0008995_early_reproductive_senescence | 0.94911402 |
| 104 | MP0005085_abnormal_gallbladder_physiolo | 0.94361774 |
| 105 | MP0005195_abnormal_posterior_eye | 0.92870441 |
| 106 | MP0004885_abnormal_endolymph | 0.92560369 |
| 107 | MP0004019_abnormal_vitamin_homeostasis | 0.92545931 |
| 108 | MP0005174_abnormal_tail_pigmentation | 0.90221647 |
| 109 | MP0006035_abnormal_mitochondrial_morpho | 0.89739465 |
| 110 | MP0000026_abnormal_inner_ear | 0.89208347 |
| 111 | MP0001879_abnormal_lymphatic_vessel | 0.88750642 |
| 112 | MP0004142_abnormal_muscle_tone | 0.88028361 |
| 113 | MP0002938_white_spotting | 0.86474708 |
| 114 | MP0003566_abnormal_cell_adhesion | 0.86246341 |
| 115 | MP0002128_abnormal_blood_circulation | 0.86152884 |
| 116 | MP0002148_abnormal_hypersensitivity_rea | 0.84728356 |
| 117 | MP0004147_increased_porphyrin_level | 0.82688179 |
| 118 | MP0003122_maternal_imprinting | 0.82066664 |
| 119 | MP0002234_abnormal_pharynx_morphology | 0.81929006 |
| 120 | MP0003724_increased_susceptibility_to | 0.81360643 |
| 121 | MP0000647_abnormal_sebaceous_gland | 0.79432984 |
| 122 | MP0004043_abnormal_pH_regulation | 0.78578609 |
| 123 | MP0005084_abnormal_gallbladder_morpholo | 0.76625276 |
| 124 | MP0003632_abnormal_nervous_system | 0.76391843 |
| 125 | MP0006054_spinal_hemorrhage | 0.75705260 |
| 126 | MP0005666_abnormal_adipose_tissue | 0.75275311 |
| 127 | MP0002063_abnormal_learning/memory/cond | 0.75186774 |
| 128 | MP0005647_abnormal_sex_gland | 0.74921355 |
| 129 | MP0003631_nervous_system_phenotype | 0.74874701 |
| 130 | MP0005451_abnormal_body_composition | 0.71682021 |
| 131 | MP0002909_abnormal_adrenal_gland | 0.70768554 |
| 132 | MP0000767_abnormal_smooth_muscle | 0.70301322 |
| 133 | MP0005266_abnormal_metabolism | 0.70300646 |
| 134 | MP0003941_abnormal_skin_development | 0.63518881 |
| 135 | MP0001984_abnormal_olfaction | 0.60730182 |
| 136 | MP0005623_abnormal_meninges_morphology | 0.59433831 |
| 137 | MP0002925_abnormal_cardiovascular_devel | 0.57187369 |
| 138 | MP0005377_hearing/vestibular/ear_phenot | 0.56666962 |
| 139 | MP0003878_abnormal_ear_physiology | 0.56666962 |
| 140 | MP0009697_abnormal_copulation | 0.55622534 |
| 141 | MP0005595_abnormal_vascular_smooth | 0.54554868 |
| 142 | MP0002108_abnormal_muscle_morphology | 0.54280590 |
| 143 | MP0008004_abnormal_stomach_pH | 0.52428343 |
| 144 | MP0003984_embryonic_growth_retardation | 0.49940674 |
| 145 | MP0004272_abnormal_basement_membrane | 0.48696919 |
| 146 | MP0002088_abnormal_embryonic_growth/wei | 0.48195992 |
| 147 | MP0005319_abnormal_enzyme/_coenzyme | 0.45351043 |
| 148 | MP0002078_abnormal_glucose_homeostasis | 0.45023083 |
| 149 | MP0001784_abnormal_fluid_regulation | 0.43430168 |
| 150 | MP0001614_abnormal_blood_vessel | 0.42185433 |
| 151 | MP0005375_adipose_tissue_phenotype | 0.40939499 |
| 152 | MP0000566_synostosis | 0.40647449 |
| 153 | MP0003948_abnormal_gas_homeostasis | 0.38396026 |
| 154 | MP0005386_behavior/neurological_phenoty | 0.37946081 |
| 155 | MP0004924_abnormal_behavior | 0.37946081 |
| 156 | MP0001529_abnormal_vocalization | 0.33339966 |
| 157 | MP0002133_abnormal_respiratory_system | 0.31237617 |
| 158 | MP0005388_respiratory_system_phenotype | 0.31237617 |
| 159 | MP0005646_abnormal_pituitary_gland | 0.30613753 |
| 160 | MP0005535_abnormal_body_temperature | 0.29426664 |
| 161 | MP0005503_abnormal_tendon_morphology | 0.28407883 |
| 162 | MP0002822_catalepsy | 0.26925904 |
| 163 | MP0001765_abnormal_ion_homeostasis | 0.25923043 |
| 164 | MP0006072_abnormal_retinal_apoptosis | 0.22982299 |
| 165 | MP0009384_cardiac_valve_regurgitation | 0.22698151 |
| 166 | MP0000249_abnormal_blood_vessel | 0.21430529 |
| 167 | MP0005380_embryogenesis_phenotype | 0.20473872 |
| 168 | MP0001672_abnormal_embryogenesis/_devel | 0.20473872 |
| 169 | MP0003953_abnormal_hormone_level | 0.20402845 |
| 170 | MP0002877_abnormal_melanocyte_morpholog | 0.20311261 |
| 171 | MP0003935_abnormal_craniofacial_develop | 0.19634815 |
| 172 | MP0000003_abnormal_adipose_tissue | 0.18965449 |
| 173 | MP0005187_abnormal_penis_morphology | 0.17471996 |
| 174 | MP0001853_heart_inflammation | 0.17311236 |
| 175 | MP0009780_abnormal_chondrocyte_physiolo | 0.16416197 |
| 176 | MP0002693_abnormal_pancreas_physiology | 0.15352923 |
| 177 | MP0001175_abnormal_lung_morphology | 0.14995253 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Sudden death (HP:0001699) | 8.96290931 |
| 2 | Ventricular tachycardia (HP:0004756) | 7.54743167 |
| 3 | * Atrial fibrillation (HP:0005110) | 7.22099196 |
| 4 | * Primary atrial arrhythmia (HP:0001692) | 6.71183244 |
| 5 | * Supraventricular tachycardia (HP:0004755) | 6.48726627 |
| 6 | * Supraventricular arrhythmia (HP:0005115) | 6.33014363 |
| 7 | Calf muscle hypertrophy (HP:0008981) | 6.19594853 |
| 8 | Lipoatrophy (HP:0100578) | 5.95309480 |
| 9 | * Syncope (HP:0001279) | 5.46734230 |
| 10 | Muscle hypertrophy of the lower extremities (HP:0008968) | 5.44156429 |
| 11 | Right ventricular cardiomyopathy (HP:0011663) | 5.40545931 |
| 12 | Exercise-induced muscle cramps (HP:0003710) | 5.38311427 |
| 13 | Subaortic stenosis (HP:0001682) | 5.29261664 |
| 14 | Abnormality of the left ventricular outflow tract (HP:0011103) | 5.29261664 |
| 15 | Palpitations (HP:0001962) | 5.20660031 |
| 16 | Abnormality of the calf musculature (HP:0001430) | 5.18200041 |
| 17 | Exercise-induced myalgia (HP:0003738) | 4.93214954 |
| 18 | Dilated cardiomyopathy (HP:0001644) | 4.92989502 |
| 19 | Myoglobinuria (HP:0002913) | 4.78488970 |
| 20 | * Prolonged QT interval (HP:0001657) | 4.69291619 |
| 21 | Ventricular arrhythmia (HP:0004308) | 4.63933937 |
| 22 | Bundle branch block (HP:0011710) | 4.44204708 |
| 23 | Muscle fiber splitting (HP:0003555) | 4.41725066 |
| 24 | Abnormality of liposaccharide metabolism (HP:0010968) | 4.39796857 |
| 25 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 4.39796857 |
| 26 | Abnormality of glycolipid metabolism (HP:0010969) | 4.39796857 |
| 27 | Pancreatic cysts (HP:0001737) | 4.33342042 |
| 28 | Ventricular fibrillation (HP:0001663) | 4.00881030 |
| 29 | Hyporeflexia of lower limbs (HP:0002600) | 3.95069297 |
| 30 | Hyperventilation (HP:0002883) | 3.93380366 |
| 31 | Asymmetric septal hypertrophy (HP:0001670) | 3.85829095 |
| 32 | Increased cerebral lipofuscin (HP:0011813) | 3.76154816 |
| 33 | Pancreatic fibrosis (HP:0100732) | 3.72622067 |
| 34 | Abolished electroretinogram (ERG) (HP:0000550) | 3.71540698 |
| 35 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 3.71362619 |
| 36 | Congenital stationary night blindness (HP:0007642) | 3.62282391 |
| 37 | EMG: myopathic abnormalities (HP:0003458) | 3.62245089 |
| 38 | True hermaphroditism (HP:0010459) | 3.61329195 |
| 39 | Molar tooth sign on MRI (HP:0002419) | 3.59066788 |
| 40 | Abnormality of midbrain morphology (HP:0002418) | 3.59066788 |
| 41 | Left ventricular hypertrophy (HP:0001712) | 3.58822881 |
| 42 | * Abnormal EKG (HP:0003115) | 3.58790223 |
| 43 | * Heart block (HP:0012722) | 3.42550405 |
| 44 | Vacuolated lymphocytes (HP:0001922) | 3.41576522 |
| 45 | Rhabdomyolysis (HP:0003201) | 3.36101411 |
| 46 | Abnormal mitochondria in muscle tissue (HP:0008316) | 3.31660856 |
| 47 | Hepatic necrosis (HP:0002605) | 3.29306567 |
| 48 | Acute necrotizing encephalopathy (HP:0006965) | 3.27686320 |
| 49 | Nephronophthisis (HP:0000090) | 3.23646022 |
| 50 | * Abnormal atrioventricular conduction (HP:0005150) | 3.16915732 |
| 51 | * Atrioventricular block (HP:0001678) | 3.14835515 |
| 52 | Hypoglycemic coma (HP:0001325) | 3.14626881 |
| 53 | Congenital sensorineural hearing impairment (HP:0008527) | 3.09745476 |
| 54 | Type II lissencephaly (HP:0007260) | 3.08553076 |
| 55 | Abnormality of the renal cortex (HP:0011035) | 3.03973370 |
| 56 | Abnormality of the renal medulla (HP:0100957) | 3.01533756 |
| 57 | Abnormality of pyruvate family amino acid metabolism (HP:0010915) | 2.99956205 |
| 58 | Abnormality of alanine metabolism (HP:0010916) | 2.99956205 |
| 59 | Hyperalaninemia (HP:0003348) | 2.99956205 |
| 60 | Attenuation of retinal blood vessels (HP:0007843) | 2.93970731 |
| 61 | Palmoplantar keratoderma (HP:0000982) | 2.91519150 |
| 62 | Medial flaring of the eyebrow (HP:0010747) | 2.90337674 |
| 63 | Tubular atrophy (HP:0000092) | 2.87482614 |
| 64 | Ketoacidosis (HP:0001993) | 2.81149611 |
| 65 | Ragged-red muscle fibers (HP:0003200) | 2.75055633 |
| 66 | Hepatocellular necrosis (HP:0001404) | 2.73640720 |
| 67 | Decreased electroretinogram (ERG) amplitude (HP:0000654) | 2.71986246 |
| 68 | Acute encephalopathy (HP:0006846) | 2.69057042 |
| 69 | Myotonia (HP:0002486) | 2.67454202 |
| 70 | Mitochondrial inheritance (HP:0001427) | 2.65838168 |
| 71 | Progressive macrocephaly (HP:0004481) | 2.64342619 |
| 72 | Increased connective tissue (HP:0009025) | 2.64213118 |
| 73 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 2.62321778 |
| 74 | Increased CSF lactate (HP:0002490) | 2.59770486 |
| 75 | Distal lower limb muscle weakness (HP:0009053) | 2.59650650 |
| 76 | Gaze-evoked nystagmus (HP:0000640) | 2.57537849 |
| 77 | Hypoplastic left heart (HP:0004383) | 2.57359391 |
| 78 | Cystic liver disease (HP:0006706) | 2.51943491 |
| 79 | Abnormality of fatty-acid metabolism (HP:0004359) | 2.48209218 |
| 80 | Tubulointerstitial fibrosis (HP:0005576) | 2.47466387 |
| 81 | Cerebellar dysplasia (HP:0007033) | 2.44593164 |
| 82 | Sudden cardiac death (HP:0001645) | 2.41616251 |
| 83 | Patent foramen ovale (HP:0001655) | 2.41599680 |
| 84 | Congenital hepatic fibrosis (HP:0002612) | 2.41233130 |
| 85 | Dicarboxylic aciduria (HP:0003215) | 2.40745759 |
| 86 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 2.40745759 |
| 87 | Chronic hepatic failure (HP:0100626) | 2.40735102 |
| 88 | Genetic anticipation (HP:0003743) | 2.40079061 |
| 89 | Inability to walk (HP:0002540) | 2.39832893 |
| 90 | Exercise intolerance (HP:0003546) | 2.37838846 |
| 91 | Mutism (HP:0002300) | 2.37281285 |
| 92 | Progressive cerebellar ataxia (HP:0002073) | 2.34246626 |
| 93 | * Decreased circulating renin level (HP:0003351) | 2.33448778 |
| 94 | Neoplasm of the adrenal gland (HP:0100631) | 2.31781810 |
| 95 | Lactic acidosis (HP:0003128) | 2.31514678 |
| 96 | Agitation (HP:0000713) | 2.31238477 |
| 97 | Abnormal rod and cone electroretinograms (HP:0008323) | 2.29998713 |
| 98 | Increased muscle lipid content (HP:0009058) | 2.28325755 |
| 99 | Gait imbalance (HP:0002141) | 2.26873078 |
| 100 | Absent speech (HP:0001344) | 2.26564720 |
| 101 | Mesangial abnormality (HP:0001966) | 2.26001042 |
| 102 | Hypoplasia of the uterus (HP:0000013) | 2.25409603 |
| 103 | Congenital malformation of the right heart (HP:0011723) | 2.24914111 |
| 104 | Double outlet right ventricle (HP:0001719) | 2.24914111 |
| 105 | Clumsiness (HP:0002312) | 2.23117404 |
| 106 | Generalized aminoaciduria (HP:0002909) | 2.22668084 |
| 107 | Cerebral edema (HP:0002181) | 2.22475894 |
| 108 | Central scotoma (HP:0000603) | 2.21820110 |
| 109 | Pheochromocytoma (HP:0002666) | 2.18133161 |
| 110 | Congenital primary aphakia (HP:0007707) | 2.17985824 |
| 111 | Bile duct proliferation (HP:0001408) | 2.17739528 |
| 112 | Abnormal biliary tract physiology (HP:0012439) | 2.17739528 |
| 113 | Hyperinsulinemic hypoglycemia (HP:0000825) | 2.17725449 |
| 114 | Conjunctival hamartoma (HP:0100780) | 2.15310876 |
| 115 | Progressive inability to walk (HP:0002505) | 2.14628487 |
| 116 | Pancreatic islet-cell hyperplasia (HP:0004510) | 2.13973833 |
| 117 | Protruding tongue (HP:0010808) | 2.13660490 |
| 118 | Aplasia/hypoplasia of the uterus (HP:0008684) | 2.12423397 |
| 119 | Aplasia/Hypoplasia of the tibia (HP:0005772) | 2.12190392 |
| 120 | Fair hair (HP:0002286) | 2.11132755 |
| 121 | Stomach cancer (HP:0012126) | 2.10328496 |
| 122 | Epidermoid cyst (HP:0200040) | 2.10235202 |
| 123 | * Polydipsia (HP:0001959) | 2.07905099 |
| 124 | * Abnormal drinking behavior (HP:0030082) | 2.07905099 |
| 125 | Hypokalemic alkalosis (HP:0001949) | 2.07256634 |
| 126 | Decreased central vision (HP:0007663) | 2.07246185 |
| 127 | Amelogenesis imperfecta (HP:0000705) | 2.07130507 |
| 128 | Neoplasm of head and neck (HP:0012288) | 2.06244642 |
| 129 | Esophageal neoplasm (HP:0100751) | 2.06244642 |
| 130 | Male pseudohermaphroditism (HP:0000037) | 2.05655755 |
| 131 | Keratoconus (HP:0000563) | 2.05395289 |
| 132 | Increased corneal curvature (HP:0100692) | 2.05395289 |
| 133 | Nephrogenic diabetes insipidus (HP:0009806) | 2.05172195 |
| 134 | Neuroendocrine neoplasm (HP:0100634) | 2.05072168 |
| 135 | Tubulointerstitial abnormality (HP:0001969) | 2.05033809 |
| 136 | Increased intramyocellular lipid droplets (HP:0012240) | 2.05011685 |
| 137 | * Congestive heart failure (HP:0001635) | 2.04327390 |
| 138 | Retinal atrophy (HP:0001105) | 2.02212744 |
| 139 | Respiratory failure (HP:0002878) | 1.99866439 |
| 140 | Bony spicule pigmentary retinopathy (HP:0007737) | 1.99065281 |
| 141 | Genital tract atresia (HP:0001827) | 1.98539251 |
| 142 | Abnormality of macular pigmentation (HP:0008002) | 1.98212585 |
| 143 | Centrally nucleated skeletal muscle fibers (HP:0003687) | 1.98159271 |
| 144 | Large for gestational age (HP:0001520) | 1.97792183 |
| 145 | Polyphagia (HP:0002591) | 1.96882493 |
| 146 | Hypoplastic heart (HP:0001961) | 1.95994299 |
| 147 | Severe muscular hypotonia (HP:0006829) | 1.95805133 |
| 148 | Areflexia of lower limbs (HP:0002522) | 1.95736477 |
| 149 | Neck muscle weakness (HP:0000467) | 1.95494763 |
| 150 | Generalized muscle weakness (HP:0003324) | 1.95227664 |
| 151 | Broad-based gait (HP:0002136) | 1.95134509 |
| 152 | Renal cortical cysts (HP:0000803) | 1.92932762 |
| 153 | Renal salt wasting (HP:0000127) | 1.92635719 |
| 154 | Tinnitus (HP:0000360) | 1.92630041 |
| 155 | Vaginal atresia (HP:0000148) | 1.91635214 |
| 156 | Rimmed vacuoles (HP:0003805) | 1.90846643 |
| 157 | Aplasia/Hypoplasia of the tongue (HP:0010295) | 1.90714965 |
| 158 | Nausea (HP:0002018) | 1.89835064 |
| 159 | Inappropriate behavior (HP:0000719) | 1.89348931 |
| 160 | Macular degeneration (HP:0000608) | 1.89086927 |
| 161 | Constricted visual fields (HP:0001133) | 1.88582660 |
| 162 | Anencephaly (HP:0002323) | 1.87913101 |
| 163 | Pulmonary artery stenosis (HP:0004415) | 1.87499404 |
| 164 | Difficulty running (HP:0009046) | 1.85037288 |
| 165 | Autoimmune thrombocytopenia (HP:0001973) | 1.84920740 |
| 166 | Congenital, generalized hypertrichosis (HP:0004540) | 1.84404099 |
| 167 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 1.84397391 |
| 168 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 1.84397391 |
| 169 | Abnormality of polysaccharide metabolism (HP:0011012) | 1.84397391 |
| 170 | Bradycardia (HP:0001662) | 1.83758409 |
| 171 | Retinitis pigmentosa (HP:0000510) | 1.83595824 |
| 172 | Widely spaced teeth (HP:0000687) | 1.83347386 |
| 173 | Pendular nystagmus (HP:0012043) | 1.83046009 |
| 174 | Absent rod-and cone-mediated responses on ERG (HP:0007688) | 1.82310076 |
| 175 | Dialeptic seizures (HP:0011146) | 1.82002515 |
| 176 | Disinhibition (HP:0000734) | 1.81669458 |
| 177 | * Polyuria (HP:0000103) | 1.79170341 |
| 178 | Diaphragmatic weakness (HP:0009113) | 1.78967960 |
| 179 | Dysostosis multiplex (HP:0000943) | 1.78771980 |
| 180 | Febrile seizures (HP:0002373) | 1.78482524 |
| 181 | Lipid accumulation in hepatocytes (HP:0006561) | 1.77521573 |
| 182 | Abnormality of the foot musculature (HP:0001436) | 1.77118468 |
| 183 | Furrowed tongue (HP:0000221) | 1.76896527 |
| 184 | Prostate neoplasm (HP:0100787) | 1.76467809 |
| 185 | Hyperglycemia (HP:0003074) | 1.74792904 |
| 186 | Abnormality of the endocardium (HP:0004306) | 1.74282592 |
| 187 | Disproportionate short-trunk short stature (HP:0003521) | 1.72853105 |
| 188 | Periauricular skin pits (HP:0100277) | 1.71612804 |
| 189 | Preauricular pit (HP:0004467) | 1.71612804 |
| 190 | Dysmetric saccades (HP:0000641) | 1.71198446 |
| 191 | Hypoplastic ischia (HP:0003175) | 1.71136570 |
| 192 | Ketosis (HP:0001946) | 1.70890352 |
| 193 | Muscle stiffness (HP:0003552) | 1.70623885 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | FRK | 6.34307168 |
| 2 | OBSCN | 5.43934704 |
| 3 | MYLK | 4.98958924 |
| 4 | TTN | 4.04962315 |
| 5 | ACVR1B | 3.75572403 |
| 6 | BMPR1B | 3.40480582 |
| 7 | STK24 | 3.39999398 |
| 8 | LMTK2 | 3.38991856 |
| 9 | TIE1 | 3.17754009 |
| 10 | PKN2 | 3.13833341 |
| 11 | PDK3 | 3.08680124 |
| 12 | PDK4 | 3.08680124 |
| 13 | PHKG2 | 2.99217646 |
| 14 | PHKG1 | 2.99217646 |
| 15 | DMPK | 2.86922626 |
| 16 | WNK3 | 2.78594982 |
| 17 | PIK3CA | 2.46463225 |
| 18 | INSRR | 2.45189626 |
| 19 | MUSK | 2.33348947 |
| 20 | ZAK | 2.13255303 |
| 21 | MAP4K2 | 2.02193565 |
| 22 | PINK1 | 1.91177123 |
| 23 | PDK2 | 1.89492361 |
| 24 | NEK1 | 1.89399644 |
| 25 | DAPK2 | 1.86030734 |
| 26 | FLT3 | 1.85248651 |
| 27 | BCKDK | 1.82089568 |
| 28 | GRK1 | 1.82017088 |
| 29 | TLK1 | 1.80901608 |
| 30 | TGFBR1 | 1.75597073 |
| 31 | NUAK1 | 1.70750305 |
| 32 | GRK7 | 1.69820809 |
| 33 | STK38L | 1.67986281 |
| 34 | OXSR1 | 1.64148047 |
| 35 | TAOK3 | 1.58911984 |
| 36 | MAPK13 | 1.52355484 |
| 37 | CAMK2D | 1.46001595 |
| 38 | MKNK2 | 1.40932398 |
| 39 | MAP3K4 | 1.36816192 |
| 40 | WNK4 | 1.35366254 |
| 41 | ILK | 1.34927973 |
| 42 | CAMKK2 | 1.26957603 |
| 43 | STK4 | 1.26861777 |
| 44 | TRIB3 | 1.26145379 |
| 45 | PAK3 | 1.23700199 |
| 46 | SIK3 | 1.21311955 |
| 47 | CDC42BPA | 1.19746514 |
| 48 | MARK1 | 1.15490126 |
| 49 | PRKD1 | 1.07907294 |
| 50 | NTRK3 | 1.06595829 |
| 51 | ROCK1 | 1.05572736 |
| 52 | TRPM7 | 1.05472666 |
| 53 | TXK | 1.00226841 |
| 54 | IRAK1 | 0.95670982 |
| 55 | MAP3K5 | 0.95365232 |
| 56 | CSNK1A1L | 0.93394195 |
| 57 | KDR | 0.93042373 |
| 58 | CSNK1G2 | 0.92367311 |
| 59 | MAP3K7 | 0.88705633 |
| 60 | PRKAA2 | 0.86769053 |
| 61 | MAPK12 | 0.86058756 |
| 62 | PRKCG | 0.85242362 |
| 63 | CAMK1 | 0.84423485 |
| 64 | CAMK4 | 0.84270000 |
| 65 | PRKAA1 | 0.84126607 |
| 66 | IKBKB | 0.81075900 |
| 67 | CAMK1D | 0.80708418 |
| 68 | MAP2K6 | 0.80618189 |
| 69 | MKNK1 | 0.80119329 |
| 70 | FER | 0.78473522 |
| 71 | AKT3 | 0.78281581 |
| 72 | WNK1 | 0.76269658 |
| 73 | TGFBR2 | 0.75039312 |
| 74 | CSNK1G3 | 0.74662203 |
| 75 | CSNK1G1 | 0.72685989 |
| 76 | DYRK2 | 0.72501224 |
| 77 | PLK2 | 0.71720341 |
| 78 | DAPK3 | 0.69837248 |
| 79 | EIF2AK3 | 0.69338622 |
| 80 | CAMK1G | 0.69287022 |
| 81 | PRKCE | 0.69252771 |
| 82 | CAMK2A | 0.66350509 |
| 83 | TRIM28 | 0.65555014 |
| 84 | BRSK2 | 0.63773105 |
| 85 | RPS6KL1 | 0.63589258 |
| 86 | RPS6KC1 | 0.63589258 |
| 87 | SIK1 | 0.62021477 |
| 88 | MAPKAPK5 | 0.61306844 |
| 89 | BLK | 0.58198704 |
| 90 | SGK2 | 0.58113353 |
| 91 | BCR | 0.57250475 |
| 92 | RPS6KA6 | 0.55131131 |
| 93 | SGK3 | 0.51122334 |
| 94 | DDR2 | 0.51024013 |
| 95 | STK38 | 0.49792928 |
| 96 | EPHA3 | 0.47037714 |
| 97 | CHUK | 0.46921059 |
| 98 | * PRKACA | 0.46358690 |
| 99 | PRKACB | 0.45732583 |
| 100 | RIPK1 | 0.45640166 |
| 101 | RPS6KA5 | 0.44682624 |
| 102 | MATK | 0.44185601 |
| 103 | NLK | 0.44122898 |
| 104 | NEK9 | 0.43490710 |
| 105 | MAP2K7 | 0.43183898 |
| 106 | MAPK7 | 0.42838074 |
| 107 | PTK2B | 0.41871108 |
| 108 | TEC | 0.40969540 |
| 109 | PRKACG | 0.40692347 |
| 110 | ABL2 | 0.40628950 |
| 111 | TNK2 | 0.40351348 |
| 112 | MAP2K3 | 0.39856930 |
| 113 | CSNK1A1 | 0.39428504 |
| 114 | ITK | 0.38832173 |
| 115 | ABL1 | 0.38090188 |
| 116 | MARK3 | 0.37569178 |
| 117 | PRKG2 | 0.37298053 |
| 118 | NTRK2 | 0.36236600 |
| 119 | ROCK2 | 0.34612708 |
| 120 | PKN1 | 0.32046031 |
| 121 | STK39 | 0.30274089 |
| 122 | PRKG1 | 0.30041118 |
| 123 | ADRBK2 | 0.29442319 |
| 124 | IGF1R | 0.29119899 |
| 125 | SYK | 0.26407534 |
| 126 | PRKCZ | 0.25847908 |
| 127 | STK3 | 0.25292021 |
| 128 | EPHB2 | 0.24887777 |
| 129 | AKT2 | 0.24348982 |
| 130 | PRKCH | 0.24101548 |
| 131 | ERBB3 | 0.22638922 |
| 132 | MAP3K3 | 0.22566135 |
| 133 | CAMK2G | 0.21492886 |
| 134 | TNIK | 0.21071313 |
| 135 | CASK | 0.17224767 |
| 136 | JAK1 | 0.16912153 |
| 137 | ADRBK1 | 0.15955990 |
| 138 | PRPF4B | 0.15614588 |
| 139 | LATS1 | 0.14479873 |
| 140 | SGK1 | 0.13451096 |
| 141 | PRKCQ | 0.12757003 |
| 142 | SGK494 | 0.11936702 |
| 143 | SGK223 | 0.11936702 |
| 144 | MAPKAPK3 | 0.09943018 |
| 145 | AKT1 | 0.09890515 |
| 146 | RPS6KA2 | 0.08869997 |
| 147 | RPS6KA1 | 0.08831827 |
| 148 | MARK2 | 0.08245901 |
| 149 | TAOK2 | 0.07829839 |
| 150 | RPS6KA3 | 0.07172741 |
| 151 | KIT | 0.07096787 |
| 152 | PRKCA | 0.06958034 |
| 153 | PDK1 | 0.05621327 |
| 154 | PDGFRA | 0.05611664 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 6.26277331 |
| 2 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 4.82623555 |
| 3 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 4.28454147 |
| 4 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 4.21873108 |
| 5 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 3.93950523 |
| 6 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 3.57980922 |
| 7 | Parkinsons disease_Homo sapiens_hsa05012 | 3.33057341 |
| 8 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 3.22236265 |
| 9 | Propanoate metabolism_Homo sapiens_hsa00640 | 2.88755521 |
| 10 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.67988457 |
| 11 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 2.67389725 |
| 12 | Phototransduction_Homo sapiens_hsa04744 | 2.47394370 |
| 13 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 2.46678527 |
| 14 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 2.46481803 |
| 15 | Alzheimers disease_Homo sapiens_hsa05010 | 2.36700344 |
| 16 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 2.36408756 |
| 17 | Lysosome_Homo sapiens_hsa04142 | 2.35174440 |
| 18 | Carbon metabolism_Homo sapiens_hsa01200 | 2.25723482 |
| 19 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 2.21637744 |
| 20 | Nitrogen metabolism_Homo sapiens_hsa00910 | 2.18536843 |
| 21 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 2.13923312 |
| 22 | Ether lipid metabolism_Homo sapiens_hsa00565 | 2.10105678 |
| 23 | Huntingtons disease_Homo sapiens_hsa05016 | 2.08074972 |
| 24 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 2.02680536 |
| 25 | Asthma_Homo sapiens_hsa05310 | 1.99291522 |
| 26 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.96914638 |
| 27 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 1.93589076 |
| 28 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.89148027 |
| 29 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 1.88722427 |
| 30 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.82950889 |
| 31 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.81800805 |
| 32 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.71159994 |
| 33 | Nicotine addiction_Homo sapiens_hsa05033 | 1.70723598 |
| 34 | Viral myocarditis_Homo sapiens_hsa05416 | 1.69696354 |
| 35 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 1.63385941 |
| 36 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.61820493 |
| 37 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.58494124 |
| 38 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 1.56068356 |
| 39 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.54248141 |
| 40 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.51594643 |
| 41 | ABC transporters_Homo sapiens_hsa02010 | 1.44601011 |
| 42 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 1.30468814 |
| 43 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.29204598 |
| 44 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 1.24682229 |
| 45 | Other glycan degradation_Homo sapiens_hsa00511 | 1.16571163 |
| 46 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 1.09309282 |
| 47 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 1.04463579 |
| 48 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.03972628 |
| 49 | Regulation of autophagy_Homo sapiens_hsa04140 | 1.01725411 |
| 50 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.00365131 |
| 51 | Mineral absorption_Homo sapiens_hsa04978 | 0.98385072 |
| 52 | Insulin resistance_Homo sapiens_hsa04931 | 0.97168436 |
| 53 | Calcium signaling pathway_Homo sapiens_hsa04020 | 0.95551833 |
| 54 | Graft-versus-host disease_Homo sapiens_hsa05332 | 0.95142897 |
| 55 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.94639554 |
| 56 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.94350097 |
| 57 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 0.93790907 |
| 58 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.92206679 |
| 59 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.91770311 |
| 60 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.91155095 |
| 61 | Glutamatergic synapse_Homo sapiens_hsa04724 | 0.91116061 |
| 62 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.90975690 |
| 63 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 0.89169947 |
| 64 | Histidine metabolism_Homo sapiens_hsa00340 | 0.89095425 |
| 65 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.88374158 |
| 66 | Salivary secretion_Homo sapiens_hsa04970 | 0.88052231 |
| 67 | Olfactory transduction_Homo sapiens_hsa04740 | 0.86915286 |
| 68 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.84669835 |
| 69 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.83909706 |
| 70 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.82740923 |
| 71 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.82395110 |
| 72 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.80823065 |
| 73 | * Serotonergic synapse_Homo sapiens_hsa04726 | 0.80717507 |
| 74 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.79981840 |
| 75 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.78778020 |
| 76 | Lysine degradation_Homo sapiens_hsa00310 | 0.78464015 |
| 77 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.78353746 |
| 78 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.77164927 |
| 79 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.75604630 |
| 80 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.74725461 |
| 81 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.74505587 |
| 82 | Insulin secretion_Homo sapiens_hsa04911 | 0.72806948 |
| 83 | Circadian rhythm_Homo sapiens_hsa04710 | 0.72398224 |
| 84 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.71487033 |
| 85 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.70319919 |
| 86 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.69062402 |
| 87 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.68133625 |
| 88 | Galactose metabolism_Homo sapiens_hsa00052 | 0.68040487 |
| 89 | Basal transcription factors_Homo sapiens_hsa03022 | 0.66334886 |
| 90 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.65853347 |
| 91 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.65788668 |
| 92 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.65756380 |
| 93 | Retinol metabolism_Homo sapiens_hsa00830 | 0.65043277 |
| 94 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.64492677 |
| 95 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.63788792 |
| 96 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.63180016 |
| 97 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.58621806 |
| 98 | Homologous recombination_Homo sapiens_hsa03440 | 0.57724438 |
| 99 | Focal adhesion_Homo sapiens_hsa04510 | 0.57588052 |
| 100 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.57031637 |
| 101 | * Oxytocin signaling pathway_Homo sapiens_hsa04921 | 0.51973394 |
| 102 | Taste transduction_Homo sapiens_hsa04742 | 0.51249014 |
| 103 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.50101193 |
| 104 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.48267958 |
| 105 | Renin secretion_Homo sapiens_hsa04924 | 0.48063594 |
| 106 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.48009374 |
| 107 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.46098365 |
| 108 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.45218861 |
| 109 | Phagosome_Homo sapiens_hsa04145 | 0.44727836 |
| 110 | Tuberculosis_Homo sapiens_hsa05152 | 0.44644695 |
| 111 | * Circadian entrainment_Homo sapiens_hsa04713 | 0.44070361 |
| 112 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.43490320 |
| 113 | Long-term depression_Homo sapiens_hsa04730 | 0.42208752 |
| 114 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 0.41466732 |
| 115 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.40895907 |
| 116 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.40687765 |
| 117 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.39857278 |
| 118 | Antigen processing and presentation_Homo sapiens_hsa04612 | 0.39718959 |
| 119 | ECM-receptor interaction_Homo sapiens_hsa04512 | 0.39321045 |
| 120 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.39175151 |
| 121 | Protein export_Homo sapiens_hsa03060 | 0.37458198 |
| 122 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.36374615 |
| 123 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.34463279 |
| 124 | Adherens junction_Homo sapiens_hsa04520 | 0.32547084 |
| 125 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.31760672 |
| 126 | Peroxisome_Homo sapiens_hsa04146 | 0.30930158 |
| 127 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.26607215 |
| 128 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.24745594 |
| 129 | Tight junction_Homo sapiens_hsa04530 | 0.24497201 |
| 130 | Metabolic pathways_Homo sapiens_hsa01100 | 0.23516242 |
| 131 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.22065358 |
| 132 | * Morphine addiction_Homo sapiens_hsa05032 | 0.20650002 |
| 133 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.20385519 |
| 134 | Platelet activation_Homo sapiens_hsa04611 | 0.17372464 |
| 135 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.12726424 |
| 136 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.12588407 |
| 137 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.12141866 |
| 138 | Cholinergic synapse_Homo sapiens_hsa04725 | 0.11993448 |
| 139 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 0.08603682 |
| 140 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.08475221 |
| 141 | GABAergic synapse_Homo sapiens_hsa04727 | 0.07767783 |
| 142 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.07170549 |
| 143 | PI3K-Akt signaling pathway_Homo sapiens_hsa04151 | 0.07135358 |
| 144 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 0.07095852 |
| 145 | Amoebiasis_Homo sapiens_hsa05146 | 0.07082246 |
| 146 | Purine metabolism_Homo sapiens_hsa00230 | 0.06470479 |
| 147 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.03481048 |
| 148 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.02826368 |
| 149 | Allograft rejection_Homo sapiens_hsa05330 | 0.01438010 |
| 150 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.01235955 |
| 151 | * Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 0.00836480 |
| 152 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.00216479 |
| 153 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | -0.0367932 |
| 154 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | -0.0324596 |
| 155 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | -0.0254395 |
| 156 | Rap1 signaling pathway_Homo sapiens_hsa04015 | -0.0236406 |
| 157 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | -0.0235174 |
| 158 | Legionellosis_Homo sapiens_hsa05134 | -0.0137520 |
| 159 | MAPK signaling pathway_Homo sapiens_hsa04010 | -0.0114060 |
| 160 | Notch signaling pathway_Homo sapiens_hsa04330 | -0.0111873 |

